Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.400
+0.050 (2.13%)
At close: Mar 20, 2026, 4:00 PM EDT
2.300
-0.100 (-4.17%)
After-hours: Mar 20, 2026, 7:37 PM EDT

Psyence Biomedical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
631597327
Market Cap Growth
23.78%-82.20%-84.31%-70.26%-
Enterprise Value
-2215--
Last Close Price
2.4029.894258.9839616.7437396.84
PE Ratio
-2.69---
PB Ratio
0.060.40-1.39-485.22192.35
P/TBV Ratio
0.460.40--192.35
Debt / Equity Ratio
---0.95--
Net Debt / Equity Ratio
-0.60-0.91-0.886.66-1.03
Net Debt / EBITDA Ratio
1.731.68-3.53--
Net Debt / FCF Ratio
1.681.64-3.290.841.26
Quick Ratio
7.7710.550.060.8313.62
Current Ratio
8.0911.040.090.8913.90
Return on Equity (ROE)
-74.29%---468.63%-
Return on Assets (ROA)
-34.44%-54.20%-126.35%-123.25%-
Return on Capital Employed (ROCE)
-35.00%-54.50%25.10%1613.80%-109.20%
Earnings Yield
-71.61%37.25%-335.16%-3.30%-0.57%
FCF Yield
-77.24%-137.84%-19.33%-1.64%-0.43%
Updated Nov 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q